So mutational synergy seems to predict prognosis in MM and DHL, but can we make this more personalised? To figure this out we used exome sequencing data to simulate every individual poor prognosis patient (<3yr survival) in a landmark lymphoma study.…
...from Björn Chapuy most insightful: Björn named technologies/algorithms that will likely refine the molecular classification yet again. Maybe including SDCM as explainable AI?😉 Don't miss their related key papers on #DLBCL: https://t.co/WmZVbLWsrY and…
RT @SibaElHussein: DLBCL with diffuse & strong expression of PD-L1: PD-L1 upregulation, although occasional in DLBCL, appears to be more co…
RT @SibaElHussein: DLBCL with diffuse & strong expression of PD-L1: PD-L1 upregulation, although occasional in DLBCL, appears to be more co…